Technical: 95% min. Formulation: Imidacloprid 70% wp, 25% wp, 10% wp, 200g/l SL, 100g/l SL Chemical name: 1-((6-chloro-3-pyridinyl) methyl)-n-nitro-imidazolidinimine CAS reg no.: 138261-41-3 Molecular formula: C9h10cln5o2 Molecular mass: 255.7
Technical standard: Imidacloprid 95% min. Tc Appearance white powder A. I. Content, % 95 min. Loss on drying, % 1.0 max. Soda, % 0.2 max.
Formulation standard: Imidacloprid 70% wp Appreance white powder A. I. Content, % 70.0 min. Suspensibility, % 80.0 min Wet sieve test(44um) s 98.0 min
Imidacloprid 70% ws Appreance pink powder A. I. Content, % 70.0 min. Suspensibility, % 80.0 min PH value 5.0-7.0 Water content, % 2.0 max.
Imidacloprid 25% wp Appreance white powder A. I. Content, % 25.0 min. Suspensibility, % 80.0 min Wet sieve test(44um) s 98.0 min
Imidacloprid 10% wp Appreance white powder A. I. Content, % 10.0 min. Suspensibility, % 80.0 min Wet sieve test(44um) s 98.0 min
Imidacloprid 200g/l SL Appreance yellow transparent liquid A. I. Content, g/l 200.0 min. Water content, % 0.5 max Dilution stability(200times) qualified Low-temperature qualified High-temperature qualified
Imidacloprid 100g/l SL Appreance yellow transparent liquid A. I. Content, g/l 100.0 min. Water content, % 0.5 max Dilution stability(200times) qualified Low-temperature qualified High-temperature qualified
Packing: Powder: 25kg drum or customized Liquid: 200ltr plastic drum or customized
Physicochemical properties Density: 1.54 M. P.: 144º C Vapour pressure, pa at 20º C: Negligible Solubility (20º C): In water 0.061 g/100ml Octanol/water partition coefficient as log pow: 0.57 Spillage disposal: : Sweep spilled substance into containers. Carefully collect remainder, then remove to safe place. Personal protection: P2 filter respirator for harmful particles. Do not let this chemical enter the environment. Storage: Separated from food and feedstuffs.
Toxicological: Imidacloprid given orally as a single dose was moderately toxic to rats (ld50, 380- 650 mg/kg bw) and mice (ld50, 130- 170 mg/kg bw). Behavioural and respiratory signs, disturbances of motility, narrowed palpebral fissures, transient trembling and spasms were seen in rats and mice treated orally at doses > 200 mg/kg bw and > 71 mg/kg bw, respectively. The clinical signs were reversed within 6 days. Imidacloprid given intraperitoneally showed moderate to low acute toxicity in rats, the signs being similar to those after oral administration. Very little toxicity was seen after acute dermal application. The LC50 for a single exposure to an aerosol could not be determined exactly, as rats tolerated inhalation for 4 h of the maximum concentration of dust that could be produced technically (0.069 mg/l of air) without signs or deaths.
Complaint
